Cellosaurus logo
expasy logo

Cellosaurus U-539MG (CVCL_1E99)

[Text version]
Cell line name U-539MG
Synonyms U-539 MG; U539MG; 539 MG
Accession CVCL_1E99
Resource Identification Initiative To cite this cell line use: U-539MG (RRID:CVCL_1E99)
Comments Derived from site: In situ; Brain; UBERON=UBERON_0000955.
Disease Astrocytoma (NCIt: C60781)
Astrocytoma (ORDO: Orphanet_94)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Category Cancer cell line
STR profile Source(s): PubMed=27582061

Markers:
AmelogeninX
CSF1PO9,11
D2S133820,25
D3S135815,16
D5S81811,13
D7S82010,11
D8S117913,14
D13S31711,13
D16S53911,12
D18S5115,17
D19S43313,15
D21S1129,30
FGA21,23
Penta D12,14
TH019.3
TPOX9,11
vWA17,19

Run an STR similarity search on this cell line
Publications

PubMed=4369403; DOI=10.1002/1097-0142(197408)34:2<274::AID-CNCR2820340209>3.0.CO;2-4
Wahlstrom T., Linder E., Saksela E., Westermark B.
Tumor-specific membrane antigens in established cell lines from gliomas.
Cancer 34:274-279(1974)

DOI=10.1007/978-1-4757-1647-4_7
Ponten J.
Neoplastic human glia cells in culture.
(In) Human tumor cells in vitro; Fogh J. (eds.); pp.175-206; Springer; New York (1975)

PubMed=2454731
Nister M., Libermann T.A., Betsholtz C., Pettersson M., Claesson-Welsh L., Heldin C.-H., Schlessinger J., Westermark B.
Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-alpha and their receptors in human malignant glioma cell lines.
Cancer Res. 48:3910-3918(1988)

DOI=10.1016/B978-0-12-333530-2.50005-8
Nister M., Westermark B.
Human glioma cell lines.
(In) Atlas of human tumor cell lines; Hay R.J., Park J.-G., Gazdar A.F. (eds.); pp.17-42; Academic Press; New York (1994)

PubMed=27582061; DOI=10.1126/scitranslmed.aaf6853
Allen M., Bjerke M., Edlund H., Nelander S., Westermark B.
Origin of the U87MG glioma cell line: good news and bad news.
Sci. Transl. Med. 8:354re3.1-354re3.4(2016)

Cross-references
Encyclopedic resources Wikidata; Q54973592
Entry history
Entry creation08-Jul-2015
Last entry update29-Jun-2023
Version number7